SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

ARB IOT Group Ltd. is a holding company that engages in the provision of solutions for the integration of IoT systems and devices. It operates through the Internet of Things and Investment Holding and Others segments. The company was founded on March 1, 2022 and is headquartered in Singapore.

ARB IOT Group Ltd

ARBB is trending as traders discuss its low float and potential for a short squeeze, drawing comparisons to stocks like SMX. Community members are highlighting key price levels as potential triggers for further upward momentum. Speculation is fueled by social media buzz around a prior AI server deal and the company's structure after a reverse split.

Amplify ETF Trust - Amplify Seymour Cannabis ETF

Amplify Seymour Cannabis ETF

$CNBS is trending due to renewed sector-wide optimism fueled by reports that the Trump administration may reclassify marijuana, potentially leading to significant tax relief and easier access to banking services for cannabis companies. The community is closely watching for details on the executive order, with some expressing skepticism while others highlight Tim Seymour's connection to the ETF. Overall, the ETF's volatility and potential for rapid price swings are key discussion points.

Tennant Co. engages in the design, manufacture, and marketing of cleaning solutions. Its products include equipment for maintaining surfaces in industrial, commercial, and outdoor environments, detergent-free and other sustainable cleaning technologies, cleaning tools and supplies, and coatings for protecting, repairing and upgrading surfaces. It operates through the following geographic segments: Americas, Europe, Middle East, and Africa, and Asia Pacific. The company was founded by George Henry Tennant in 1870 and is headquartered in Eden Prairie, MN.

Tennant Co.

Tennant Co. is trending as investors are evaluating a potential acquisition of Nilfisk amidst a competitive bidding environment, with some believing a merger would create synergies. Community members are also assessing the company's strategic direction, particularly regarding expansion in smaller space cleaning and the potential impact of robotics and AI. Overall sentiment is mixed, with some viewing $TNC as undervalued, while others are wary of insider selling.

Stafi is the first DeFi protocol unlocking liquidity of staked assets. Users can stake PoS tokens through Stafi and receive rTokens in return, which are available for trading while still earning staking rewards. FIS is the native token on Stafi Chain. FIS is required to provide security to the network by staking, pay for transaction fees on the Stafi chain, mint & redeem rTokens.

StaFi

StaFi's FIS token is trending amid discussions around its potential for a major price shift, particularly in relation to a descending wedge pattern and key price levels; however, a recent Binance delisting announcement has introduced concerns about volatility and potential downsides. The community is weighing the delisting news against StaFi's ongoing efforts to expand its multi-chain liquid staking infrastructure and develop AI-powered systems, creating a mixed sentiment.

The Root Network

The Root Network ($ROOT) is trending as the community discusses its potential within the metaverse and its connection to Futureverse. Conversations revolve around recent price movements, accumulation strategies, and speculation about a potential breakout similar to other metaverse projects. Some users are also highlighting partnerships and the project's ecosystem, while others are inquiring about price discrepancies across exchanges.

Berachain

Berachain ($BERA) is trending as traders discuss its Proof-of-Liquidity model and potential for future growth, while others express concerns about its performance since launch. Community members are actively debating entry points and discussing potential price targets. The recent Bectra upgrade and integrations with platforms like PAW Chain are also sparking interest.

The 401jk (just kidding) meme is a satirical punch in the gut in the face of the concept of retirement and also the 401k. The 401k total holdings are valued at around $12 trillion USD and it is the most popular retirement savings plan in the US. As time passes forevermore true retirement, or as we like to call it real freedom will only become much harder and harder for people to attain.  Through meme fueled laser focus and cyperphunk ideology the 401jK meme retirement fund token and community aim to point out the absurdities of how rigged our current system is, and how only insiders and those with power are starting the benefit from the increased centralization of cryptocurrency.........while also aiming to flip the $12 trillion USD 401k system to achieve freedom before our backs and knees are breaking.

401jK

$401JK is trending as community members rally around the idea of a decentralized retirement fund, challenging traditional 401(k) plans. Discussions highlight upcoming staking and the project's evolution from a meme to a potential financial movement. Despite some price volatility, the community expresses strong conviction and a belief in the project's long-term vision.

Onyx is an infrastructure for a multi-asset, scalable, and cryptographically secure ledger. Onyx functions as a blockchain-based technology that enhances financial ecosystems by enabling a more efficient and interconnected economy, with a mission to develop cryptographic ledgers that optimize security, scalability, and usability. XCN is native to the Onyx XCN Ledger Blockchain and as an ERC-20 token for Staking and Governance.

Onyxcoin

Onyxcoin ($XCN) is experiencing increased community chatter driven by its recent listing on Robinhood, with users speculating on increased exposure and easier access for U.S. retail investors. Bullish sentiment is further fueled by upcoming Goliath Mainnet, with some seeing the Robinhood listing as a signal of legitimacy and visibility. Community members are also sharing price predictions and discussing staking percentages.

Marriott International, Inc. engages in the operation and franchise of hotel, residential, and timeshare properties. It operates through the following geography segments: United States and Canada, Europe, Middle East, and Africa, Asia Pacific, and Greater China. Its brands include Marriott Bonvoy, The Ritz-Carlton, Edition, W Hotels Worldwide, The Luxury Collection, and Stregis Hotels and Resorts etc. The company was founded by John Willard Marriott and Alice Sheets Marriott in 1927 and is headquartered in Bethesda, MD.

Marriott International, Inc. - Ordinary Shares - Class A

Marriott International Inc

Marriott International is trending as investors analyze its growth strategy and financial outlook following its recent earnings report. The community is focused on both revenue per available room (RevPAR) and the potential impact of broader economic trends on the travel sector. Recent data breaches and executive moves are also contributing to the discussion around the stock.

Wealthfront Corp.engages in the provision of automated digital investment advisory services. The company was founded by Andrew Samuel Rachleff and Daniel Joseph Carroll in January 2007 and is headquartered in Palo Alto, CA.

Wealthfront Corp.

Wealthfront ($WLTH) is trending following its IPO, with the community discussing its potential as a long-term play in the robo-advisor space and comparing it to competitors. Some are optimistic due to strong anchor support and the company's focus on millennial and Gen Z clients, while others are awaiting chart data and analyzing its initial trading behavior. The IPO was reportedly oversubscribed, and there's chatter about potential weekend advertising and significant upside.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Artiva Biotherapeutics, Inc. (NASDAQ:ARTV) Receives Consensus Recommendation of "Moderate Buy" from Brokerages

Artiva Biotherapeutics, Inc. (NASDAQ:ARTV - Get Free Report) has been given an average rating of "Moderate Buy" by the six ratings firms that are presently covering the stock, MarketBeat Ratings...

Artiva Biotherapeutics (NASDAQ:ARTV) CEO Sells $21,547.50 in Stock

Artiva Biotherapeutics, Inc. (NASDAQ:ARTV - Get Free Report) CEO Fred Aslan sold 6,375 shares of the business's stock in a transaction on Monday, November 17th. The shares were sold at an average...

Fred Aslan Sells 6,375 Shares of Artiva Biotherapeutics (NASDAQ:ARTV) Stock

Artiva Biotherapeutics, Inc. (NASDAQ:ARTV - Get Free Report) CEO Fred Aslan sold 6,375 shares of the stock in a transaction that occurred on Monday, November 17th. The shares were sold at an average...

HC Wainwright Forecasts Strong Price Appreciation for Artiva Biotherapeutics (NASDAQ:ARTV) Stock

HC Wainwright boosted their target price on shares of Artiva Biotherapeutics from $12.00 to $15.00 and gave the company a "buy" rating in a research note on Wednesday...

Artiva Biotherapeutics (NASDAQ:ARTV) Releases Quarterly Earnings Results, Beats Expectations By $0.02 EPS

Artiva Biotherapeutics (NASDAQ:ARTV - Get Free Report) issued its quarterly earnings data on Tuesday. The company reported ($0.88) earnings per share (EPS) for the quarter, topping the consensus...

Wedbush on Friday raised its price target on Artiva Biotherapeutics, Inc. (ARTV) to $23 from $18 while keeping an ‘Outperform’ rating on the shares.The new price target implies a potential upside of 730% to the stock’s closing price on Thursday. Shares of the company rallied 99% on Friday at the time of writing.The price target hike <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.globenewswire.com/news-release/2025/10/16/3168298/0/en/artiva-biotherapeutics-announces-refractory-rheumatoid-arthritis-as-lead-indication-upcoming-data-releases-and-corporate-update.html">follows</a> the company’s announcement on Thursday that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation to its cell therapy candidate AlloNK for the treatment of refractory rheumatoid arthritis in combination with Rituximab. The company also said that it has prioritized refractory rheumatoid arthritis as the lead indication for AlloNK.“Despite the many approved therapies in RA, there are over 100,000 patients in the United States who remain treatment refractory and could potentially benefit from a deep B-cell depleting therapy,” CEO Fred Aslan explained.Rheumatoid arthritis (RA) is a chronic autoimmune disease that affects over 1.5 million people in the United States and can cause painful joint inflammation, progressive joint damage, and disability. A significant subset becomes refractory and no longer responds to or tolerates available treatment options.The company now plans to share safety and translational data for AlloNK in mid-November from patients treated with AlloNK and Rituximab across multiple autoimmune diseases, followed by clinical response data in the first half of 2026 from over 15 refractory RA patients. The CEO also added that the company is planning interactions with the FDA in the first half of 2026.On Stocktwits, retail sentiment around <a href="https://stocktwits.com/symbol/ARTV">ARTV stock</a> jumped from ‘bearish’ to ‘extremely bullish’ territory over the past 24 hours, while message volume rose from ‘extremely low’ to ‘extremely high’ levels.<figure class="image"><img style="aspect-ratio:588/62;" src="https://news.stocktwits-cdn.com/Screenshot_2025_10_17_at_10_20_08_AM_png_e279bf0c53.webp" alt="ARTV's Sentiment Meter and Message Volume as of 10:20 a.m. ET on Oct. 17, 2025 | Source: Stocktwits" width="588" height="62"><figcaption>ARTV's Sentiment Meter and Message Volume as of 10:20 a.m. ET on Oct. 17, 2025 | Source: Stocktwits</figcaption></figure>A Stocktwits user expects the stock to rally further.<stembedurl>https://stocktwits.com/bzspy/message/632725500</stembedurl>ARTV stock is down by 45% this year and by 57% over the past 12 months.&nbsp;Read also:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/tesla-supervised-autonomy-analyst-warns-ahead-q3-earnings-valuation-177x-pe/ch6rM5XR3Fe">Tesla Still In ‘Supervised Autonomy,’ Says Analyst As Q3 Earnings Day Nears: ‘Shouldn’t Trade At 177x P/E’</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Rising stock market chart on a trading board background.

Artiva Biotherapeutics Gets A Price Target Hike From Wedbush: Stock Rallies 99% But Retail Expects Further Rally

Wedbush’s new price target implies a whopping 730% potential upside to the stock’s closing price on Thursday.

Equity

Wedbush’s new price target implies a whopping 730% potential upside to the stock’s closing price on Thursday.


Artiva Biotherapeutics, Inc. operates as a biotechnology company for the treatment of hematologic cancers. It offers NK cell therapies for cancer. The company was founded by Thomas J. Farrell in 2019 and is headquartered in San Diego, CA.

ARTV
Artiva Biotherapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest ARTV News

ARTVArtiva Biotherapeutics Inc